INTERMEDIATE UVEITIS AFTER COVID-19 INFECTION

A CASE REPORT

Abstract

Introduction: In the medical literature, multiple descriptions of ophthalmological manifestations have been attributed, directly or indirectly, to COVID-19. The increase in ocular surface symptoms, such as dry eye, were correlated by increasing exposure to digital life, during isolation period in pandemia. The signs of vascular involvement are well documented, such as retinal hemorrhages and also of intraocular inflammation, called uveitis. We describe a case of intermediate uveitis after COVID-19 infection. Case report: A 50-year-old man with positive Polymerase Chain Reaction (PCR) in a nasal swab for SARS-VOC-2, ten days after isolation, complained of low visual acuity and bilateral visual blurring. Vitreitis in both eyes, 2 + / 4 OD and 1 + / 4 + OE and vitreous haze were documented in simple retinography. Fifteen days after the early diagnosis and the start of treatment, the patient evolved with improved visual acuity. In the reassessment of biomicroscopy and fundscopy, there was an improvement in the vitreitis pattern. Discussion: The patient denied a medical history of chronic autoimmune and inflammatory diseases, and other etiologies were excluded. The clinical presentation, early diagnosis and satisfactory response suggest a subacute intermediate uveitis. Conclusion: We present this case of ocular involvement, days after a systemic inflammatory condition by COVID-19, to document the extraordinary and multifaceted capacity for clinical manifestation of this virus.